Healthcare Stocks: 540 U.S.-Listed Companies by Market Cap
EquiReason covers 540 U.S.-listed companies in the Healthcare sector, with a combined market cap of $8.60T. The largest by market cap: Eli Lilly and Company (LLY, $1.20T), Johnson & Johnson (JNJ, $635.1B), AbbVie Inc. (ABBV, $504.8B), UnitedHealth Group Incorporated (UNH, $375.3B), Merck & Co., Inc. (MRK, $358.4B).
Sector and industry classification and market cap at the latest close: EquiReason company data · financial statements on each company's page come from its SEC filings
Industries in Healthcare
Biotechnology (219) · Medical Devices (67) · Drug Manufacturers - General (56) · Medical Instruments & Supplies (44) · Drug Manufacturers - Specialty & Generic (40) · Diagnostics & Research (36) · Medical Care Facilities (36) · Health Information Services (24) · Healthcare Plans (11) · Medical Distribution (6) · Pharmaceutical Retailers (1)
Companies by market cap
| # | Company | Industry | Market cap |
|---|---|---|---|
| 1 | LLY Eli Lilly and Company | Drug Manufacturers - General | $1.20T |
| 2 | JNJ Johnson & Johnson | Drug Manufacturers - General | $635.1B |
| 3 | ABBV AbbVie Inc. | Drug Manufacturers - General | $504.8B |
| 4 | UNH UnitedHealth Group Incorporated | Healthcare Plans | $375.3B |
| 5 | MRK Merck & Co., Inc. | Drug Manufacturers - General | $358.4B |
| 6 | AZN AstraZeneca PLC | Drug Manufacturers - General | $274.1B |
| 7 | TMO Thermo Fisher Scientific Inc. | Diagnostics & Research | $249.1B |
| 8 | AMGN Amgen Inc. | Drug Manufacturers - General | $237.5B |
| 9 | GILD Gilead Sciences, Inc. | Drug Manufacturers - General | $193.5B |
| 10 | ABT Abbott Laboratories | Medical Devices | $179.4B |
| 11 | PFE Pfizer Inc. | Drug Manufacturers - General | $171.2B |
| 12 | DHR Danaher Corporation | Diagnostics & Research | $162.2B |
| 13 | ISRG Intuitive Surgical, Inc. | Medical Instruments & Supplies | $156.8B |
| 14 | VRTX Vertex Pharmaceuticals Incorporated | Biotechnology | $132.8B |
| 15 | BMY Bristol-Myers Squibb Company | Drug Manufacturers - General | $125.6B |
| 16 | MDT Medtronic plc | Medical Devices | $122.0B |
| 17 | CVS CVS Health Corporation | Healthcare Plans | $119.5B |
| 18 | SYK Stryker Corporation | Medical Devices | $117.8B |
| 19 | MCK McKesson Corporation | Medical Distribution | $116.7B |
| 20 | HCA HCA Healthcare, Inc. | Medical Care Facilities | $101.5B |
| 21 | ELV Elevance Health, Inc. | Healthcare Plans | $95.1B |
| 22 | REGN Regeneron Pharmaceuticals, Inc. | Biotechnology | $82.9B |
| 23 | CI The Cigna Group | Healthcare Plans | $81.1B |
| 24 | MRNA Moderna, Inc. | Biotechnology | $79.9B |
| 25 | BSX Boston Scientific Corporation | Medical Devices | $66.2B |
| 26 | COR Cencora, Inc. | Medical Distribution | $63.2B |
| 27 | NTRA Natera, Inc. | Diagnostics & Research | $58.2B |
| 28 | CAH Cardinal Health, Inc. | Medical Distribution | $58.0B |
| 29 | BDX Becton, Dickinson and Company | Medical Instruments & Supplies | $54.2B |
| 30 | VEEV Veeva Systems Inc. | Health Information Services | $52.3B |
| 31 | EW Edwards Lifesciences Corporation | Medical Devices | $51.3B |
| 32 | HUM Humana Inc. | Healthcare Plans | $50.7B |
| 33 | A Agilent Technologies, Inc. | Diagnostics & Research | $48.8B |
| 34 | IQV IQVIA Holdings Inc. | Diagnostics & Research | $46.0B |
| 35 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Drug Manufacturers - General | $45.9B |
| 36 | MDLN Medline Inc. | Medical Instruments & Supplies | $44.8B |
| 37 | WAT Waters Corporation | Diagnostics & Research | $44.6B |
| 38 | IDXX IDEXX Laboratories, Inc. | Diagnostics & Research | $44.1B |
| 39 | ONC BeOne Medicines Ltd. | Drug Manufacturers - General | $42.9B |
| 40 | ILMN Illumina, Inc. | Diagnostics & Research | $40.7B |
| 41 | RVMD Revolution Medicines, Inc. | Biotechnology | $40.1B |
| 42 | BIIB Biogen Inc. | Drug Manufacturers - General | $37.0B |
| 43 | RPRX Royalty Pharma plc | Biotechnology | $36.7B |
| 44 | RMD ResMed Inc. | Medical Instruments & Supplies | $36.5B |
| 45 | CNC Centene Corporation | Healthcare Plans | $34.7B |
| 46 | ZTS Zoetis Inc. | Drug Manufacturers - Specialty & Generic | $33.5B |
| 47 | MTD Mettler-Toledo International Inc. | Diagnostics & Research | $33.5B |
| 48 | GEHC GE HealthCare Technologies Inc. | Medical Devices | $32.3B |
| 49 | ALNY Alnylam Pharmaceuticals, Inc. | Biotechnology | $30.0B |
| 50 | DXCM DexCom, Inc. | Medical Devices | $29.4B |
| 51 | WST West Pharmaceutical Services, Inc. | Medical Instruments & Supplies | $27.6B |
| 52 | LH Labcorp Holdings Inc. | Diagnostics & Research | $26.7B |
| 53 | DGX Quest Diagnostics Incorporated | Diagnostics & Research | $26.6B |
| 54 | ROIV Roivant Sciences Ltd. | Biotechnology | $26.4B |
| 55 | UTHR United Therapeutics Corporation | Drug Manufacturers - Specialty & Generic | $25.2B |
| 56 | INCY Incyte Corporation | Biotechnology | $23.5B |
| 57 | GH Guardant Health, Inc. | Diagnostics & Research | $22.7B |
| 58 | STE STERIS plc | Medical Devices | $22.6B |
| 59 | THC Tenet Healthcare Corporation | Medical Care Facilities | $21.6B |
| 60 | VTRS Viatris Inc. | Drug Manufacturers - Specialty & Generic | $20.7B |
| 61 | INSM Insmed Incorporated | Biotechnology | $20.4B |
| 62 | ZBH Zimmer Biomet Holdings, Inc. | Medical Devices | $18.8B |
| 63 | MEDP Medpace Holdings, Inc. | Diagnostics & Research | $18.7B |
| 64 | RVTY Revvity, Inc. | Diagnostics & Research | $17.7B |
| 65 | CRL Charles River Laboratories International, Inc. | Diagnostics & Research | $16.5B |
| 66 | EXEL Exelixis, Inc. | Biotechnology | $16.0B |
| 67 | ASND Ascendis Pharma A/S | Biotechnology | $15.1B |
| 68 | SOLV Solventum Corporation | Medical Instruments & Supplies | $14.5B |
| 69 | NBIX Neurocrine Biosciences, Inc. | Drug Manufacturers - Specialty & Generic | $14.5B |
| 70 | ICLR ICON PLC | Diagnostics & Research | $14.3B |
| 71 | HALO Halozyme Therapeutics, Inc. | Biotechnology | $14.3B |
| 72 | JAZZ Jazz Pharmaceuticals plc | Biotechnology | $13.9B |
| 73 | BBIO BridgeBio Pharma, Inc. | Biotechnology | $13.4B |
| 74 | BAX Baxter International Inc. | Medical Instruments & Supplies | $13.1B |
| 75 | PEN Penumbra, Inc. | Medical Devices | $12.8B |
| 76 | SMMT Summit Therapeutics Inc. | Biotechnology | $12.3B |
| 77 | EHC Encompass Health Corporation | Medical Care Facilities | $12.2B |
| 78 | TEM Tempus AI, Inc. | Health Information Services | $12.2B |
| 79 | BTSG BrightSpring Health Services, Inc. | Health Information Services | $11.9B |
| 80 | DVA DaVita Inc. | Medical Care Facilities | $11.7B |
| 81 | AVTR Avantor, Inc. | Medical Instruments & Supplies | $11.7B |
| 82 | COO The Cooper Companies, Inc. | Medical Instruments & Supplies | $11.6B |
| 83 | TECH Bio-Techne Corporation | Biotechnology | $11.4B |
| 84 | ELAN Elanco Animal Health Incorporated | Drug Manufacturers - Specialty & Generic | $11.3B |
| 85 | UHS Universal Health Services, Inc. | Medical Care Facilities | $11.0B |
| 86 | ALGN Align Technology, Inc. | Medical Instruments & Supplies | $11.0B |
| 87 | QGEN Qiagen N.V. | Diagnostics & Research | $10.9B |
| 88 | GMED Globus Medical, Inc. | Medical Devices | $10.9B |
| 89 | MOH Molina Healthcare, Inc. | Healthcare Plans | $10.9B |
| 90 | BMRN BioMarin Pharmaceutical Inc. | Biotechnology | $10.8B |
| 91 | GKOS Glaukos Corporation | Medical Devices | $10.6B |
| 92 | PODD Insulet Corporation | Medical Devices | $10.3B |
| 93 | ENSG The Ensign Group, Inc. | Medical Care Facilities | $10.2B |
| 94 | MDGL Madrigal Pharmaceuticals, Inc. | Biotechnology | $10.0B |
| 95 | RGEN Repligen Corporation | Medical Instruments & Supplies | $10.0B |
| 96 | BIO Bio-Rad Laboratories, Inc. | Medical Devices | $9.9B |
| 97 | OSCR Oscar Health, Inc. | Healthcare Plans | $9.6B |
| 98 | HSIC Henry Schein, Inc. | Medical Distribution | $9.5B |
| 99 | TXG 10x Genomics, Inc. | Health Information Services | $9.3B |
| 100 | CORT Corcept Therapeutics Incorporated | Biotechnology | $9.3B |
| 101 | KRYS Krystal Biotech, Inc. | Biotechnology | $9.2B |
| 102 | KYMR Kymera Therapeutics, Inc. | Biotechnology | $9.2B |
| 103 | CAI Caris Life Sciences, Inc. | Biotechnology | $9.0B |
| 104 | HNGE Hinge Health, Inc. | Health Information Services | $9.0B |
| 105 | PCVX Vaxcyte, Inc. | Biotechnology | $9.0B |
| 106 | PTGX Protagonist Therapeutics, Inc. | Biotechnology | $9.0B |
| 107 | BRKR Bruker Corporation | Medical Devices | $8.8B |
| 108 | TWST Twist Bioscience Corporation | Diagnostics & Research | $8.8B |
| 109 | IBRX ImmunityBio, Inc. | Biotechnology | $8.7B |
| 110 | HQY HealthEquity, Inc. | Health Information Services | $8.6B |
| 111 | CYTK Cytokinetics, Incorporated | Biotechnology | $8.5B |
| 112 | TGTX TG Therapeutics, Inc. | Biotechnology | $8.3B |
| 113 | ARWR Arrowhead Pharmaceuticals, Inc. | Biotechnology | $8.2B |
| 114 | ATR AptarGroup, Inc. | Medical Instruments & Supplies | $8.0B |
| 115 | SYRE Spyre Therapeutics, Inc. | Biotechnology | $8.0B |
| 116 | AXSM Axsome Therapeutics, Inc. | Biotechnology | $7.6B |
| 117 | PACS PACS Group, Inc. | Medical Care Facilities | $7.5B |
| 118 | ALKS Alkermes plc | Drug Manufacturers - Specialty & Generic | $7.3B |
| 119 | IONS Ionis Pharmaceuticals, Inc. | Biotechnology | $7.1B |
| 120 | PRAX Praxis Precision Medicines, Inc. | Biotechnology | $7.1B |
| 121 | CHE Chemed Corporation | Medical Care Facilities | $6.7B |
| 122 | LNTH Lantheus Holdings, Inc. | Drug Manufacturers - Specialty & Generic | $6.5B |
| 123 | AMRX Amneal Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $6.5B |
| 124 | HIMS Hims & Hers Health, Inc. | Drug Manufacturers - Specialty & Generic | $6.5B |
| 125 | IOVA Iovance Biotherapeutics, Inc. | Biotechnology | $6.4B |
| 126 | BLCO Bausch & Lomb Corp | Medical Instruments & Supplies | $6.2B |
| 127 | RYTM Rhythm Pharmaceuticals, Inc. | Biotechnology | $6.1B |
| 128 | LGND Ligand Pharmaceuticals Incorporated | Biotechnology | $6.1B |
| 129 | DOCS Doximity, Inc. | Health Information Services | $6.0B |
| 130 | KNSA Kiniksa Pharmaceuticals International, plc | Drug Manufacturers - Specialty & Generic | $6.0B |
| 131 | GRAL GRAIL, Inc. | Diagnostics & Research | $5.9B |
| 132 | IMVT Immunovant, Inc. | Biotechnology | $5.9B |
| 133 | MANE Veradermics, Incorporated | Biotechnology | $5.8B |
| 134 | BLTE BELITE BIO, INC | Drug Manufacturers - General | $5.8B |
| 135 | TFX Teleflex Incorporated | Medical Instruments & Supplies | $5.8B |
| 136 | MMSI Merit Medical Systems, Inc. | Medical Instruments & Supplies | $5.6B |
| 137 | RDNT RadNet, Inc. | Diagnostics & Research | $5.5B |
| 138 | WAY Waystar Holding Corp. | Health Information Services | $5.5B |
| 139 | KOD Kodiak Sciences Inc. | Biotechnology | $5.5B |
| 140 | CGON CG Oncology, Inc. | Biotechnology | $5.5B |
| 141 | COGT Cogent Biosciences, Inc. | Biotechnology | $5.4B |
| 142 | HAE Haemonetics Corporation | Medical Devices | $5.4B |
| 143 | ORKA Oruka Therapeutics, Inc. | Biotechnology | $5.3B |
| 144 | MIRM Mirum Pharmaceuticals, Inc. | Biotechnology | $5.2B |
| 145 | SHC Sotera Health Company | Diagnostics & Research | $5.2B |
| 146 | MMED MiniMed Group, Inc. | Medical Instruments & Supplies | $5.2B |
| 147 | BLLN BillionToOne, Inc. | Diagnostics & Research | $5.1B |
| 148 | PTCT PTC Therapeutics, Inc. | Biotechnology | $5.1B |
| 149 | SRRK Scholar Rock Holding Corporation | Biotechnology | $5.1B |
| 150 | ERAS Erasca, Inc. | Biotechnology | $5.0B |
| 151 | CON Concentra Group Holdings Parent, Inc. | Medical Care Facilities | $5.0B |
| 152 | MMEDV MiniMed Group, Inc. | Medical Instruments & Supplies | $5.0B |
| 153 | LFST LifeStance Health Group, Inc. | Medical Care Facilities | $4.9B |
| 154 | HTFL Heartflow, Inc. | Health Information Services | $4.9B |
| 155 | DFTX Definium Therapeutics, Inc. | Biotechnology | $4.8B |
| 156 | CRSP CRISPR Therapeutics AG | Biotechnology | $4.8B |
| 157 | TVTX Travere Therapeutics, Inc. | Biotechnology | $4.7B |
| 158 | OPCH Option Care Health, Inc. | Medical Care Facilities | $4.7B |
| 159 | GOSS Gossamer Bio, Inc. | Biotechnology | $4.6B |
| 160 | LIVN LivaNova PLC | Medical Devices | $4.5B |
| 161 | ITGR Integer Holdings Corporation | Medical Devices | $4.3B |
| 162 | DNTH Dianthus Therapeutics, Inc. | Biotechnology | $4.3B |
| 163 | EWTX Edgewise Therapeutics, Inc. | Biotechnology | $4.3B |
| 164 | ICUI ICU Medical, Inc. | Medical Instruments & Supplies | $4.2B |
| 165 | ADPT Adaptive Biotechnologies Corporation | Diagnostics & Research | $4.1B |
| 166 | INDV Indivior Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $4.1B |
| 167 | IRTC iRhythm Holdings, Inc. | Medical Devices | $4.0B |
| 168 | RLAY Relay Therapeutics, Inc. | Biotechnology | $4.0B |
| 169 | TNGX Tango Therapeutics, Inc. | Biotechnology | $3.9B |
| 170 | ARQT Arcutis Biotherapeutics, Inc. | Biotechnology | $3.9B |
| 171 | VCYT Veracyte, Inc. | Diagnostics & Research | $3.9B |
| 172 | LQDA Liquidia Corporation | Drug Manufacturers - Specialty & Generic | $3.8B |
| 173 | RGC Regencell Bioscience Holdings Ltd | Drug Manufacturers - Specialty & Generic | $3.8B |
| 174 | NVST Envista Holdings Corporation | Medical Instruments & Supplies | $3.8B |
| 175 | PLSE Pulse Biosciences, Inc. | Medical Instruments & Supplies | $3.8B |
| 176 | NHC National HealthCare Corporation | Medical Care Facilities | $3.7B |
| 177 | ABCL AbCellera Biologics Inc. | Drug Manufacturers - General | $3.6B |
| 178 | OGN Organon & Co. | Drug Manufacturers - General | $3.6B |
| 179 | CDNA CareDx, Inc. | Diagnostics & Research | $3.6B |
| 180 | XENE Xenon Pharmaceuticals Inc. | Biotechnology | $3.4B |
| 181 | ACAD ACADIA Pharmaceuticals Inc. | Biotechnology | $3.4B |
| 182 | IDYA IDEAYA Biosciences, Inc. | Biotechnology | $3.3B |
| 183 | WRBY Warby Parker Inc. | Medical Instruments & Supplies | $3.2B |
| 184 | CELC Celcuity Inc. | Biotechnology | $3.2B |
| 185 | AMLX Amylyx Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $3.0B |
| 186 | ELVN Enliven Therapeutics, Inc. | Biotechnology | $3.0B |
| 187 | ATRC AtriCure, Inc. | Medical Instruments & Supplies | $3.0B |
| 188 | TARS Tarsus Pharmaceuticals, Inc. | Biotechnology | $3.0B |
| 189 | DNLI Denali Therapeutics Inc. | Biotechnology | $2.9B |
| 190 | ACHC Acadia Healthcare Company, Inc. | Medical Care Facilities | $2.9B |
| 191 | AVAH Aveanna Healthcare Holdings Inc. | Medical Care Facilities | $2.9B |
| 192 | DYN Dyne Therapeutics, Inc. | Biotechnology | $2.9B |
| 193 | PRVA Privia Health Group, Inc. | Health Information Services | $2.9B |
| 194 | IRON Disc Medicine, Inc. | Biotechnology | $2.9B |
| 195 | VKTX Viking Therapeutics, Inc. | Biotechnology | $2.8B |
| 196 | NRIX Nurix Therapeutics, Inc. | Biotechnology | $2.8B |
| 197 | ZLAB Zai Lab Ltd | Drug Manufacturers - General | $2.7B |
| 198 | NEOG Neogen Corporation | Medical Devices | $2.7B |
| 199 | VRDN Viridian Therapeutics, Inc. | Biotechnology | $2.5B |
| 200 | HCM HUTCHMED (China) Ltd | Drug Manufacturers - General | $2.5B |
| 201 | GRDN Guardian Pharmacy Services, Inc. | Medical Care Facilities | $2.5B |
| 202 | BEAM Beam Therapeutics Inc. | Biotechnology | $2.5B |
| 203 | TMDX TransMedics Group, Inc. | Medical Devices | $2.5B |
| 204 | CLOV Clover Health Investments, Corp. | Healthcare Plans | $2.4B |
| 205 | BHC Bausch Health Companies Inc. | Drug Manufacturers - General | $2.4B |
| 206 | BKD Brookdale Senior Living Inc. | Medical Care Facilities | $2.4B |
| 207 | ADMA ADMA Biologics, Inc. | Biotechnology | $2.4B |
| 208 | MD Pediatrix Medical Group, Inc. | Medical Care Facilities | $2.4B |
| 209 | SUPN Supernus Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $2.4B |
| 210 | RCUS Arcus Biosciences, Inc. | Biotechnology | $2.4B |
| 211 | NAMS NewAmsterdam Pharma Co N.V. | Drug Manufacturers - General | $2.4B |
| 212 | MBX MBX Biosciences, Inc. | Biotechnology | $2.3B |
| 213 | SLS SELLAS Life Sciences Group, Inc. | Biotechnology | $2.3B |
| 214 | CLDX Celldex Therapeutics, Inc. | Biotechnology | $2.3B |
| 215 | UFPT UFP Technologies, Inc. | Medical Devices | $2.3B |
| 216 | ADUS Addus HomeCare Corporation | Medical Care Facilities | $2.3B |
| 217 | PBH Prestige Consumer Healthcare Inc. | Drug Manufacturers - Specialty & Generic | $2.3B |
| 218 | FTRE Fortrea Holdings Inc. | Biotechnology | $2.2B |
| 219 | AUPH Aurinia Pharmaceuticals Inc. | Biotechnology | $2.2B |
| 220 | PGNY Progyny, Inc. | Healthcare Plans | $2.2B |
| 221 | PGEN Precigen, Inc. | Biotechnology | $2.2B |
| 222 | PRGO Perrigo Company plc | Drug Manufacturers - Specialty & Generic | $2.2B |
| 223 | AGIO Agios Pharmaceuticals, Inc. | Biotechnology | $2.2B |
| 224 | VCEL Vericel Corporation | Biotechnology | $2.2B |
| 225 | NEO NeoGenomics, Inc. | Diagnostics & Research | $2.1B |
| 226 | HRMY Harmony Biosciences Holdings, Inc. | Biotechnology | $2.1B |
| 227 | BHVN Biohaven Ltd. | Biotechnology | $2.1B |
| 228 | ASTH Astrana Health, Inc. | Medical Care Facilities | $2.1B |
| 229 | SGRY Surgery Partners, Inc. | Medical Care Facilities | $2.1B |
| 230 | INSP Inspire Medical Systems, Inc. | Medical Devices | $2.1B |
| 231 | AXGN Axogen, Inc. | Medical Devices | $2.0B |
| 232 | IMNM Immunome, Inc. | Biotechnology | $2.0B |
| 233 | VERA Vera Therapeutics, Inc. | Biotechnology | $2.0B |
| 234 | TRLV Trulieve Cannabis Corp. | Drug Manufacturers - Specialty & Generic | $2.0B |
| 235 | ZYME Zymeworks Inc. | Biotechnology | $2.0B |
| 236 | RXRX Recursion Pharmaceuticals, Inc. | Biotechnology | $2.0B |
| 237 | BCRX BioCryst Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $2.0B |
| 238 | LMAT LeMaitre Vascular, Inc. | Medical Instruments & Supplies | $1.9B |
| 239 | BRVE Braveheart Bio, Inc. | Drug Manufacturers - General | $1.9B |
| 240 | ESTA Establishment Labs Holdings Inc. | Medical Devices | $1.9B |
| 241 | MRVI Maravai LifeSciences Holdings, Inc. | Biotechnology | $1.9B |
| 242 | SEPN Septerna, Inc. | Biotechnology | $1.9B |
| 243 | XRAY DENTSPLY SIRONA Inc. | Medical Instruments & Supplies | $1.9B |
| 244 | SRPT Sarepta Therapeutics, Inc. | Biotechnology | $1.9B |
| 245 | XNCR Xencor, Inc. | Biotechnology | $1.9B |
| 246 | XERS Xeris Biopharma Holdings, Inc. | Drug Manufacturers - Specialty & Generic | $1.9B |
| 247 | AMN AMN Healthcare Services, Inc. | Medical Care Facilities | $1.9B |
| 248 | MLYS Mineralys Therapeutics, Inc. | Biotechnology | $1.8B |
| 249 | PVLA Palvella Therapeutics, Inc. | Biotechnology | $1.8B |
| 250 | BFLY Butterfly Network, Inc. | Medical Devices | $1.8B |
| 251 | TRVI Trevi Therapeutics, Inc. | Biotechnology | $1.8B |
| 252 | VIR Vir Biotechnology, Inc. | Biotechnology | $1.8B |
| 253 | ZBIO Zenas BioPharma, Inc. | Biotechnology | $1.8B |
| 254 | ARDT Ardent Health, Inc. | Medical Care Facilities | $1.7B |
| 255 | MAZE Maze Therapeutics, Inc. | Biotechnology | $1.7B |
| 256 | OMCL Omnicell, Inc. | Health Information Services | $1.7B |
| 257 | ATEC Alphatec Holdings, Inc. | Medical Devices | $1.7B |
| 258 | KMTS Kestra Medical Technologies, Ltd. | Medical Instruments & Supplies | $1.7B |
| 259 | NVCR NovoCure Limited | Medical Devices | $1.7B |
| 260 | HCSG Healthcare Services Group, Inc. | Medical Care Facilities | $1.7B |
| 261 | PSNL Personalis, Inc. | Diagnostics & Research | $1.7B |
| 262 | URGN UroGen Pharma Ltd. | Biotechnology | $1.7B |
| 263 | WGS GeneDx Holdings Corp. | Diagnostics & Research | $1.7B |
| 264 | ALHC Alignment Healthcare, Inc. | Healthcare Plans | $1.7B |
| 265 | ANIP ANI Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $1.7B |
| 266 | KLRA Kailera Therapeutics, Inc. | Biotechnology | $1.7B |
| 267 | SNDA Sonida Senior Living, Inc. | Medical Care Facilities | $1.6B |
| 268 | STOK Stoke Therapeutics, Inc. | Biotechnology | $1.6B |
| 269 | NUVB Nuvation Bio Inc. | Biotechnology | $1.6B |
| 270 | NVAX Novavax, Inc. | Biotechnology | $1.6B |
| 271 | AZTA Azenta, Inc. | Medical Instruments & Supplies | $1.6B |
| 272 | IMCR Immunocore Holdings plc | Biotechnology | $1.6B |
| 273 | GENB Generate Biomedicines, Inc. | Drug Manufacturers - General | $1.6B |
| 274 | CERT Certara, Inc. | Health Information Services | $1.6B |
| 275 | ABSI Absci Corporation | Biotechnology | $1.6B |
| 276 | PAHC Phibro Animal Health Corporation | Drug Manufacturers - Specialty & Generic | $1.6B |
| 277 | TRAX First Tracks Biotherapeutics, Inc. | Biotechnology | $1.6B |
| 278 | NTLA Intellia Therapeutics, Inc. | Biotechnology | $1.6B |
| 279 | QURE uniQure N.V. | Drug Manufacturers - General | $1.6B |
| 280 | CMPS COMPASS Pathways plc | Drug Manufacturers - General | $1.5B |
| 281 | RARE Ultragenyx Pharmaceutical Inc. | Biotechnology | $1.5B |
| 282 | GPCR Structure Therapeutics Inc. | Drug Manufacturers - General | $1.5B |
| 283 | AGL agilon health, inc. | Medical Care Facilities | $1.5B |
| 284 | INVA Innoviva, Inc. | Biotechnology | $1.5B |
| 285 | CNMD CONMED Corporation | Medical Devices | $1.5B |
| 286 | PNTG The Pennant Group, Inc. | Medical Care Facilities | $1.5B |
| 287 | PCRX Pacira BioSciences, Inc. | Drug Manufacturers - Specialty & Generic | $1.5B |
| 288 | ANAB AnaptysBio, Inc. | Biotechnology | $1.4B |
| 289 | NUTX Nutex Health Inc. | Medical Care Facilities | $1.4B |
| 290 | ETON Eton Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $1.4B |
| 291 | OCUL Ocular Therapeutix, Inc. | Biotechnology | $1.4B |
| 292 | INBX Inhibrx Biosciences, Inc. | Biotechnology | $1.4B |
| 293 | ORIC ORIC Pharmaceuticals, Inc. | Biotechnology | $1.4B |
| 294 | USPH U.S. Physical Therapy, Inc. | Medical Care Facilities | $1.3B |
| 295 | INNV InnovAge Holding Corp. | Medical Care Facilities | $1.3B |
| 296 | DMRA Damora Therapeutics, Inc. | Biotechnology | $1.3B |
| 297 | TSHA Taysha Gene Therapies, Inc. | Biotechnology | $1.3B |
| 298 | NKTR Nektar Therapeutics | Biotechnology | $1.3B |
| 299 | BVS Bioventus Inc. | Medical Devices | $1.3B |
| 300 | LBRX LB Pharmaceuticals Inc | Biotechnology | $1.2B |
| 301 | RAPP Rapport Therapeutics, Inc. | Biotechnology | $1.2B |
| 302 | CRON Cronos Group Inc. | Drug Manufacturers - Specialty & Generic | $1.2B |
| 303 | TYRA Tyra Biosciences, Inc. | Biotechnology | $1.2B |
| 304 | OPK OPKO Health, Inc. | Diagnostics & Research | $1.2B |
| 305 | ENOV Enovis Corporation | Medical Devices | $1.2B |
| 306 | DRTS Alpha Tau Medical Ltd. | Medical Instruments & Supplies | $1.2B |
| 307 | TNDM Tandem Diabetes Care, Inc. | Medical Devices | $1.2B |
| 308 | OMER Omeros Corporation | Biotechnology | $1.2B |
| 309 | SNDX Syndax Pharmaceuticals, Inc. | Biotechnology | $1.2B |
| 310 | OMDA Omada Health, Inc. | Health Information Services | $1.2B |
| 311 | AVLN Avalyn Pharma Inc. | Biotechnology | $1.2B |
| 312 | TDOC Teladoc Health, Inc. | Health Information Services | $1.2B |
| 313 | PRCT PROCEPT BioRobotics Corporation | Medical Devices | $1.1B |
| 314 | AORT Artivion, Inc. | Medical Devices | $1.1B |
| 315 | STAA STAAR Surgical Company | Medical Instruments & Supplies | $1.1B |
| 316 | BCAX Bicara Therapeutics Inc. | Biotechnology | $1.1B |
| 317 | LMRI Lumexa Imaging Holdings, Inc. | Diagnostics & Research | $1.1B |
| 318 | IRMD IRADIMED CORPORATION | Medical Devices | $1.1B |
| 319 | REPL Replimune Group, Inc. | Biotechnology | $1.1B |
| 320 | VOR Vor Biopharma Inc. | Biotechnology | $1.1B |
| 321 | AMPH Amphastar Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $1.1B |
| 322 | HROW Harrow, Inc. | Drug Manufacturers - Specialty & Generic | $1.1B |
| 323 | CBLL CeriBell, Inc. | Medical Devices | $1.0B |
| 324 | AVBP ArriVent BioPharma, Inc. | Biotechnology | $1.0B |
| 325 | HSTM HealthStream, Inc. | Health Information Services | $1.0B |
| 326 | MNKD MannKind Corporation | Biotechnology | $1.0B |
| 327 | JANX Janux Therapeutics, Inc. | Biotechnology | $1.0B |
| 328 | CSTL Castle Biosciences, Inc. | Diagnostics & Research | $1.0B |
| 329 | MLTX MoonLake Immunotherapeutics | Drug Manufacturers - General | $1.0B |
| 330 | SIBN SI-BONE, Inc. | Medical Devices | $962.7M |
| 331 | QDEL QuidelOrtho Corporation | Medical Devices | $941.5M |
| 332 | SLN Silence Therapeutics plc | Drug Manufacturers - General | $929.3M |
| 333 | JBIO Jade Biosciences, Inc. | Biotechnology | $927.9M |
| 334 | IART Integra LifeSciences Holdings Corporation | Medical Devices | $926.6M |
| 335 | GLUE Monte Rosa Therapeutics, Inc. | Biotechnology | $924.8M |
| 336 | CGEM Cullinan Therapeutics, Inc. | Biotechnology | $924.8M |
| 337 | VSTM Verastem, Inc. | Biotechnology | $909.3M |
| 338 | RIGL Rigel Pharmaceuticals, Inc. | Biotechnology | $899.1M |
| 339 | CRVS Corvus Pharmaceuticals, Inc. | Biotechnology | $885.8M |
| 340 | INMD InMode Ltd. | Medical Devices | $885.1M |
| 341 | MGTX MeiraGTx Holdings plc | Biotechnology | $884.6M |
| 342 | ALMS Alumis Inc. | Biotechnology | $877.6M |
| 343 | AKTS Aktis Oncology, Inc. | Biotechnology | $874.9M |
| 344 | SVRA Savara Inc. | Biotechnology | $867.0M |
| 345 | ANRO Alto Neuroscience, Inc. | Biotechnology | $862.1M |
| 346 | BBNX Beta Bionics, Inc. | Medical Devices | $862.0M |
| 347 | KURA Kura Oncology, Inc. | Biotechnology | $854.9M |
| 348 | ABUS Arbutus Biopharma Corporation | Biotechnology | $831.0M |
| 349 | AHCO AdaptHealth Corp. | Medical Devices | $820.8M |
| 350 | PHR Phreesia, Inc. | Health Information Services | $788.3M |
| 351 | FDMT 4D Molecular Therapeutics, Inc. | Biotechnology | $779.5M |
| 352 | VREX Varex Imaging Corporation | Medical Devices | $775.5M |
| 353 | ARDX Ardelyx, Inc. | Biotechnology | $767.5M |
| 354 | ANNX Annexon, Inc. | Biotechnology | $766.7M |
| 355 | COLL Collegium Pharmaceutical, Inc. | Drug Manufacturers - Specialty & Generic | $747.5M |
| 356 | CTKB Cytek Biosciences, Inc. | Medical Devices | $726.6M |
| 357 | GERN Geron Corporation | Biotechnology | $719.6M |
| 358 | SANA Sana Biotechnology, Inc. | Biotechnology | $697.5M |
| 359 | STLN Starling Oncology, Inc. | Medical Care Facilities | $683.9M |
| 360 | OABI OmniAb, Inc. | Biotechnology | $677.5M |
| 361 | DNA Ginkgo Bioworks Holdings, Inc. | Biotechnology | $672.7M |
| 362 | ACHV Achieve Life Sciences, Inc. | Biotechnology | $667.8M |
| 363 | PRME Prime Medicine, Inc. | Biotechnology | $665.7M |
| 364 | PACB Pacific Biosciences of California, Inc. | Medical Devices | $655.9M |
| 365 | AURA Aura Biosciences, Inc. | Biotechnology | $653.3M |
| 366 | NVCT Nuvectis Pharma, Inc. | Drug Manufacturers - General | $653.3M |
| 367 | GYRE GYRE THERAPEUTICS, INC. | Drug Manufacturers - General | $652.3M |
| 368 | DSGN Design Therapeutics, Inc. | Biotechnology | $640.8M |
| 369 | AKTX Akari Therapeutics Plc | Drug Manufacturers - General | $640.6M |
| 370 | KIDS OrthoPediatrics Corp. | Medical Devices | $639.7M |
| 371 | SLDB Solid Biosciences Inc. | Biotechnology | $634.8M |
| 372 | LXRX Lexicon Pharmaceuticals, Inc. | Biotechnology | $631.8M |
| 373 | WVE Wave Life Sciences Ltd. | Biotechnology | $626.6M |
| 374 | CADL Candel Therapeutics, Inc. | Biotechnology | $614.4M |
| 375 | CRMD CorMedix Inc. | Biotechnology | $611.9M |
| 376 | SGMT Sagimet Biosciences Inc. | Biotechnology | $595.5M |
| 377 | SDGR Schrödinger, Inc. | Health Information Services | $593.5M |
| 378 | WEAV Weave Communications, Inc. | Health Information Services | $592.0M |
| 379 | CLYM Climb Bio Inc | Biotechnology | $585.3M |
| 380 | IMMX Immix Biopharma, Inc. | Biotechnology | $583.0M |
| 381 | ZVRA Zevra Therapeutics, Inc. | Biotechnology | $582.6M |
| 382 | DBVT DBV Technologies S.A. | Biotechnology | $577.3M |
| 383 | AVR Anteris Technologies Global Corp. | Medical Instruments & Supplies | $572.1M |
| 384 | IRWD Ironwood Pharmaceuticals, Inc. | Drug Manufacturers - Specialty & Generic | $570.1M |
| 385 | MDXG MiMedx Group, Inc. | Biotechnology | $569.9M |
| 386 | PBYI PUMA BIOTECHNOLOGY, INC. | Drug Manufacturers - General | $568.9M |
| 387 | OLMA Olema Pharmaceuticals, Inc. | Biotechnology | $560.9M |
| 388 | MYGN Myriad Genetics, Inc. | Diagnostics & Research | $556.7M |
| 389 | FLGT Fulgent Genetics, Inc. | Diagnostics & Research | $553.1M |
| 390 | ACRS Aclaris Therapeutics, Inc. | Biotechnology | $552.0M |
| 391 | STTK Shattuck Labs, Inc. | Drug Manufacturers - General | $551.0M |
| 392 | SBC SBC Medical Group Holdings Inc | Medical Care Facilities | $543.0M |
| 393 | EVH Evolent Health, Inc. | Health Information Services | $542.7M |
| 394 | TCMD Tactile Systems Technology, Inc. | Medical Devices | $535.5M |
| 395 | ANGO AngioDynamics, Inc. | Medical Instruments & Supplies | $520.0M |
| 396 | CTMX CytomX Therapeutics, Inc. | Biotechnology | $505.5M |
| 397 | MCTA Charming Medical Ltd | Medical Care Facilities | $504.3M |
| 398 | AQST Aquestive Therapeutics, Inc. | Drug Manufacturers - Specialty & Generic | $502.0M |
| 399 | DCTH DELCATH SYSTEMS, INC. | Medical Instruments & Supplies | $500.4M |
| 400 | SGHT Sight Sciences, Inc. | Medical Instruments & Supplies | $495.2M |
| 401 | NRC NRC Health | Health Information Services | $485.1M |
| 402 | RCEL AVITA Medical, Inc. | Medical Devices | $479.7M |
| 403 | ARVN Arvinas, Inc. | Biotechnology | $477.3M |
| 404 | CBIO CRESCENT BIOPHARMA, INC. | Drug Manufacturers - General | $476.2M |
| 405 | MASS 908 Devices Inc. | Medical Devices | $474.9M |
| 406 | MNPR Monopar Therapeutics Inc. | Biotechnology | $474.2M |
| 407 | NGNE Neurogene Inc. | Biotechnology | $471.3M |
| 408 | DMAC DiaMedica Therapeutics Inc. | Drug Manufacturers - General | $470.2M |
| 409 | CERS Cerus Corporation | Medical Devices | $469.6M |
| 410 | PHAT Phathom Pharmaceuticals, Inc. | Biotechnology | $464.4M |
| 411 | EOLS Evolus, Inc. | Drug Manufacturers - Specialty & Generic | $463.0M |
| 412 | SSII SS Innovations International, Inc. | Medical Instruments & Supplies | $450.9M |
| 413 | NPCE NeuroPace, Inc. | Medical Devices | $443.1M |
| 414 | RGNX REGENXBIO Inc. | Biotechnology | $441.0M |
| 415 | ALLO Allogene Therapeutics, Inc. | Biotechnology | $431.9M |
| 416 | OVID Ovid Therapeutics Inc. | Drug Manufacturers - General | $421.8M |
| 417 | PRTA Prothena Corporation plc | Biotechnology | $421.0M |
| 418 | TLRY Tilray Brands, Inc. | Drug Manufacturers - Specialty & Generic | $415.3M |
| 419 | ALT Altimmune, Inc. | Biotechnology | $412.4M |
| 420 | SRTA Strata Critical Medical, Inc. | Medical Care Facilities | $412.3M |
| 421 | CYH Community Health Systems, Inc. | Medical Care Facilities | $411.7M |
| 422 | AUTL Autolus Therapeutics plc | Biotechnology | $409.9M |
| 423 | SI SHOULDER INNOVATIONS, INC. | Medical Instruments & Supplies | $409.3M |
| 424 | ASMB ASSEMBLY BIOSCIENCES, INC. | Drug Manufacturers - General | $404.0M |
| 425 | SPRY ARS Pharmaceuticals, Inc. | Biotechnology | $400.8M |
| 426 | OFIX Orthofix Medical Inc. | Medical Devices | $399.6M |
| 427 | CARL CARLSMED, INC. | Medical Instruments & Supplies | $396.7M |
| 428 | TECX Tectonic Therapeutic, Inc. | Biotechnology | $392.4M |
| 429 | EMBC Embecta Corp. | Medical Instruments & Supplies | $380.2M |
| 430 | CCCC C4 Therapeutics, Inc. | Biotechnology | $376.5M |
| 431 | VMD Viemed Healthcare, Inc. | Medical Devices | $373.3M |
| 432 | RZLT Rezolute, Inc. | Drug Manufacturers - General | $372.9M |
| 433 | AVTX Avalo Therapeutics, Inc. | Biotechnology | $371.7M |
| 434 | MPLT MapLight Therapeutics, Inc. | Biotechnology | $369.6M |
| 435 | EDIT Editas Medicine, Inc. | Biotechnology | $368.6M |
| 436 | NBP NovaBridge Biosciences | Drug Manufacturers - General | $365.5M |
| 437 | FENC FENNEC PHARMACEUTICALS INC. | Biotechnology | $353.5M |
| 438 | YDES YD Bio Ltd | Diagnostics & Research | $350.7M |
| 439 | CV CapsoVision, Inc | Medical Devices | $349.8M |
| 440 | RLMD Relmada Therapeutics, Inc. | Biotechnology | $348.8M |
| 441 | CAPR Capricor Therapeutics, Inc. | Biotechnology | $344.8M |
| 442 | TKNO Alpha Teknova, Inc. | Diagnostics & Research | $344.7M |
| 443 | ENTA Enanta Pharmaceuticals, Inc. | Biotechnology | $339.0M |
| 444 | OBIO Orchestra BioMed Holdings, Inc. | Medical Instruments & Supplies | $336.0M |
| 445 | KYTX Kyverna Therapeutics, Inc. | Biotechnology | $333.3M |
| 446 | AVIR Atea Pharmaceuticals, Inc. | Biotechnology | $324.0M |
| 447 | ZURA Zura Bio Ltd | Biotechnology | $322.0M |
| 448 | GALT GALECTIN THERAPEUTICS INC | Drug Manufacturers - General | $321.7M |
| 449 | XFOR X4 Pharmaceuticals, Inc | Biotechnology | $321.2M |
| 450 | EBS Emergent BioSolutions Inc. | Drug Manufacturers - Specialty & Generic | $319.4M |
| 451 | CTNM Contineum Therapeutics, Inc. | Drug Manufacturers - General | $312.6M |
| 452 | QSI Quantum-Si incorporated | Medical Devices | $306.4M |
| 453 | TTRX Turn Therapeutics Inc. | Drug Manufacturers - General | $306.2M |
| 454 | BNTC Benitec Biopharma Inc. | Drug Manufacturers - General | $301.7M |
| 455 | SMTI Sanara MedTech Inc. | Medical Instruments & Supplies | $301.4M |
| 456 | PRLD Prelude Therapeutics Inc | Drug Manufacturers - General | $289.7M |
| 457 | IRD Opus Genetics, Inc. | Drug Manufacturers - General | $288.7M |
| 458 | ANIK Anika Therapeutics, Inc. | Drug Manufacturers - Specialty & Generic | $286.7M |
| 459 | CGC Canopy Growth Corp | Drug Manufacturers - Specialty & Generic | $285.9M |
| 460 | OSUR OraSure Technologies, Inc. | Medical Instruments & Supplies | $284.8M |
| 461 | QNRX Quoin Pharmaceuticals, Ltd. | Drug Manufacturers - General | $282.6M |
| 462 | FULC Fulcrum Therapeutics, Inc. | Biotechnology | $280.8M |
| 463 | ARCT Arcturus Therapeutics Holdings Inc. | Biotechnology | $279.7M |
| 464 | CLPT ClearPoint Neuro, Inc. | Medical Devices | $278.8M |
| 465 | TMCI Treace Medical Concepts, Inc. | Medical Devices | $277.7M |
| 466 | AMRN AMARIN CORP PLC\UK | Drug Manufacturers - General | $261.2M |
| 467 | FATE Fate Therapeutics, Inc. | Biotechnology | $252.8M |
| 468 | ABEO ABEONA THERAPEUTICS INC. | Drug Manufacturers - General | $251.6M |
| 469 | RCKT Rocket Pharmaceuticals, Inc. | Biotechnology | $251.4M |
| 470 | OCGN Ocugen, Inc. | Biotechnology | $250.8M |
| 471 | LRMR Larimar Therapeutics, Inc. | Biotechnology | $244.1M |
| 472 | VNDA Vanda Pharmaceuticals Inc. | Biotechnology | $242.5M |
| 473 | LAB Standard BioTools Inc. | Medical Devices | $237.7M |
| 474 | DRUG Bright Minds Biosciences Inc. | Biotechnology | $237.4M |
| 475 | UTMD Utah Medical Products, Inc. | Medical Instruments & Supplies | $236.3M |
| 476 | BIOA BioAge Labs, Inc. | Drug Manufacturers - Specialty & Generic | $234.1M |
| 477 | PALI PALISADE BIO, INC. | Biotechnology | $231.8M |
| 478 | LYEL Lyell Immunopharma, Inc. | Drug Manufacturers - General | $230.1M |
| 479 | LXEO Lexeo Therapeutics, Inc. | Biotechnology | $229.7M |
| 480 | SIGA SIGA Technologies, Inc. | Drug Manufacturers - Specialty & Generic | $224.2M |
| 481 | KROS Keros Therapeutics, Inc. | Biotechnology | $223.7M |
| 482 | IKT Inhibikase Therapeutics, Inc. | Biotechnology | $221.9M |
| 483 | SPOK Spok Holdings, Inc. | Health Information Services | $215.5M |
| 484 | RXST RxSight, Inc. | Medical Devices | $208.8M |
| 485 | ALEC Alector, Inc. | Biotechnology | $204.3M |
| 486 | NAGE Niagen Bioscience, Inc. | Biotechnology | $192.3M |
| 487 | INGN Inogen, Inc. | Medical Devices | $188.4M |
| 488 | EVMN Evommune, Inc. | Drug Manufacturers - General | $185.1M |
| 489 | GLAS Glass House Brands Inc. | Drug Manufacturers - Specialty & Generic | $185.1M |
| 490 | ADCT ADC Therapeutics SA | Biotechnology | $183.8M |
| 491 | CATX Perspective Therapeutics, Inc. | Medical Devices | $183.8M |
| 492 | KRRO Korro Bio, Inc. | Biotechnology | $176.4M |
| 493 | OPRX OptimizeRx Corporation | Health Information Services | $172.3M |
| 494 | TRDA Entrada Therapeutics, Inc. | Biotechnology | $171.7M |
| 495 | SION Sionna Therapeutics, Inc. | Biotechnology | $162.8M |
| 496 | AKBA Akebia Therapeutics, Inc. | Drug Manufacturers - Specialty & Generic | $157.1M |
| 497 | CHRS Coherus Oncology, Inc. | Biotechnology | $156.0M |
| 498 | MDWD MediWound Ltd. | Biotechnology | $154.0M |
| 499 | UPB Upstream Bio, Inc. | Biotechnology | $150.1M |
| 500 | MXCT MaxCyte, Inc. | Medical Devices | $144.5M |
| 501 | RNA Atrium Therapeutics, Inc. | Biotechnology | $140.3M |
| 502 | CDXS Codexis, Inc. | Biotechnology | $140.2M |
| 503 | CMPX Compass Therapeutics, Inc. | Biotechnology | $137.0M |
| 504 | QTRX Quanterix Corporation | Medical Devices | $135.3M |
| 505 | NKTX Nkarta, Inc. | Biotechnology | $128.2M |
| 506 | ORGO Organogenesis Holdings Inc. | Drug Manufacturers - Specialty & Generic | $127.8M |
| 507 | HCAT Health Catalyst, Inc. | Health Information Services | $127.2M |
| 508 | AVXL Anavex Life Sciences Corp. | Biotechnology | $123.3M |
| 509 | HUMA Humacyte, Inc. | Biotechnology | $121.0M |
| 510 | FHTX Foghorn Therapeutics Inc. | Drug Manufacturers - General | $118.8M |
| 511 | DH Definitive Healthcare Corp. | Health Information Services | $115.3M |
| 512 | VYGR Voyager Therapeutics, Inc. | Biotechnology | $107.2M |
| 513 | LENZ LENZ Therapeutics, Inc. | Biotechnology | $99.3M |
| 514 | LUNG Pulmonx Corporation | Medical Devices | $78.6M |
| 515 | HRTX Heron Therapeutics, Inc. | Biotechnology | $57.5M |
| 516 | YARW Yarrow Bioscience, Inc. | Drug Manufacturers - General | $51.4M |
| 517 | ALDX Aldeyra Therapeutics, Inc. | Biotechnology | $39.2M |
| 518 | CVRX CVRx, Inc. | Medical Devices | $37.8M |
| 519 | EYPT EyePoint, Inc. | Biotechnology | $34.9M |
| 520 | IRLA Quince Therapeutics, Inc. | Biotechnology | $33.6M |
| 521 | IBO IMPACT BIOMEDICAL INC. | Drug Manufacturers - General | $30.8M |
| 522 | RMTI ROCKWELL MEDICAL, INC. | Drug Manufacturers - General | $28.0M |
| 523 | NNOX Nano-X Imaging Ltd. | Medical Devices | $26.9M |
| 524 | DCGO DocGo Inc. | Medical Care Facilities | $26.8M |
| 525 | YI 111, Inc. | Pharmaceutical Retailers | $25.1M |
| 526 | CCM Concord Medical Services Holdings Ltd | Medical Care Facilities | $17.6M |
| 527 | ACH Accendra Health, Inc. | Medical Distribution | $16.7M |
| 528 | PMI Picard Medical, Inc. | Medical Instruments & Supplies | $16.6M |
| 529 | CTSO Cytosorbents Corp | Medical Instruments & Supplies | $16.6M |
| 530 | ATYR aTyr Pharma, Inc. | Biotechnology | $16.2M |
| 531 | ZJYL Jin Medical International Ltd. | Medical Instruments & Supplies | $16.0M |
| 532 | ARAY Accuray Incorporated | Medical Devices | $15.5M |
| 533 | GUTS FRACTYL HEALTH, INC. | Medical Instruments & Supplies | $14.3M |
| 534 | GTBP GT Biopharma, Inc. | Drug Manufacturers - General | $9.9M |
| 535 | CMMB Chemomab Therapeutics Ltd. | Drug Manufacturers - General | $7.5M |
| 536 | MEDS DataMEDS AI, Inc. | Medical Distribution | $6.8M |
| 537 | ADVB Advanced Biomed Inc. | Diagnostics & Research | $5.2M |
| 538 | LGVN Longeveron Inc. | Drug Manufacturers - General | $5.1M |
| 539 | SCNI Scinai Immunotherapeutics Ltd. | Biotechnology | $3.2M |
| 540 | ENLV Enlivex Ltd. | Drug Manufacturers - General | $2.9M |
Questions
- What are the largest healthcare stocks?
- By market cap: Eli Lilly and Company (LLY) $1.20T, Johnson & Johnson (JNJ) $635.1B, AbbVie Inc. (ABBV) $504.8B, UnitedHealth Group Incorporated (UNH) $375.3B, Merck & Co., Inc. (MRK) $358.4B, AstraZeneca PLC (AZN) $274.1B, Thermo Fisher Scientific Inc. (TMO) $249.1B, Amgen Inc. (AMGN) $237.5B, Gilead Sciences, Inc. (GILD) $193.5B, Abbott Laboratories (ABT) $179.4B.
- How many healthcare companies are listed in the U.S.?
- EquiReason covers 540 U.S.-listed companies in this sector; the full list is above.
How these figures are read: methodology · EquiReason.